Philip Morris International Powers Profits with ZYN and IQOS—How Long Can the Surge Last?

Philip Morris International’s recent quarterly performance demonstrates a complex financial picture characterized by several positive developments interspersed with notable challenges. In terms of results, the company showcased significant growth trajectories within its smoke-free product segment, encompassing products like IQOS, ZYN, and VEEV. This performance contributed substantially to the overall financial outcome, resulting in a robust double-digit increase in adjusted diluted earnings per share in both constant currency and U.S. dollar terms.